News & Analysis as of October 18, 2024

Investors

+ Follow

A repository for the most well-read content on JD Supra at any given time, along with occasional roundups of popular content by specific topic. Also stop by for monthly recaps of hot articles for the previous... more +

California Passes Law Requiring Attorney General Approval for Certain Healthcare Investments and Emphasizes Requirements for...

Wilson Sonsini Goodrich & Rosati on 9/13/2024

Pre-Closing Notice or Consent: If signed by Governor Newsom, Assembly Bill 3129 (AB 3129) will mandate that, starting January 1, 2025, certain healthcare investors provide a 90-day written notice to, or obtain consent from,...more

Artificial Intelligence: Is the Health Care Sector Ready for the Rollout?

Foley & Lardner LLP on 8/20/2024

On July 17, 2024, Foley & Lardner LLP hosted the Boston Health Care AI & Technology Investor Summit with Endeavor Venture Funds, bringing together hundreds of attendees in person and virtually to discuss issues surrounding...more

Quarterly Healthcare Transactions Review: Unveiling the Latest Industry Mergers and Acquisitions [Q1 2024]

Ankura on 7/18/2024

Ankura is pleased to present an overview of healthcare transactions announced or closed during Q1 2024 in the United States. Total transactions decreased by 7.6% in the first quarter of 2024 after remaining relatively flat in...more

Healthcare Trends & Transactions Q2 2024

Bass, Berry & Sims PLC on 7/17/2024

Deal volume across the healthcare industry generally appears to have steadied despite headwinds. The general sentiment is that buyers have adapted to the current interest rates and are gritting their teeth and pressing...more

Will Regulatory Scrutiny Impact Private Equity Investment in Healthcare?

Ankura on 6/19/2024

Private Equity in Healthcare - Over the past decade, private equity investors have shown a particular interest in acquiring or investing in various healthcare providers and services. This includes physician practices across...more

2024 Healthcare Private Equity Outlook & Trends

Bass, Berry & Sims PLC on 1/9/2024

W ith various headwinds resulting in down volume in 2023, buyers and sellers alike find themselves asking whether 2024 will see a rebound in deal activity. As we begin 2024, we have highlighted the issues and trends that...more

Healthcare Trends & Transactions Q2 2023

Bass, Berry & Sims PLC on 7/28/2023

The healthcare M&A market appears to be steadying. Although deal activity through the year appears slightly below the high-water marks for the corresponding period of 2022, deal activity is generally up from the first quarter...more

Telehealth: A New Opportunity for Fraudsters

The Volkov Law Group on 7/5/2023

Whenever new technologies emerge or new pots of government funds for assistance are available, you can count on one thing (as the sun rises and sets) – fraudsters will figure out a way to steal money from innocent persons and...more

HPE Miami 2023 | Assessing Market Conditions in the Current Economic Environment

McDermott Will & Emery on 4/20/2023

Partner Andrea Zazulia moderated a panel during the Independent Healthcare Company Transactions Forum that focused on the ripple effects of recent market dynamics and the short- and long-term prognosis for healthcare...more

HPE Miami 2023 | Getting Tactical: What Healthcare Investment Bankers Think

McDermott Will & Emery on 4/10/2023

During this session, Partner David Ivill moderated a panel featuring investment bankers at leading financial institutions that discussed the big economic themes they predict for the year ahead, particularly as they impact...more

Inside the Courts – An Update From Skadden Securities Litigators - March 2023

Skadden, Arps, Slate, Meagher & Flom LLP on 3/16/2023

Circuits Split Over Whether Targeting Is Necessary for Seller Liability - Key Points - - While courts have long held that solicitations must be tailored to a particular audience to precipitate statutory seller liability,...more

Global healthcare M&A delivers strong performance

White & Case LLP on 1/25/2023

Dealmaking in the pharma, medical and biotech (PMB) subsectors was driven by both old and new market trends in 2022 - Following a ground-breaking year for dealmaking in 2021, global healthcare M&A remained robust in 2022,...more

[Event] 2019 Healthcare Services Private Equity Leadership Forum - October 25th, New York, NY

McDermott Will & Emery on 9/25/2019

Among the most active markets in private equity, the healthcare industry is ripe with opportunity for players in the healthcare services arena that can navigate the fast-paced deal environment and complex regulatory...more

[Event] 2019 European Healthcare Services Private Equity Leadership Forum - September 26th, London, United Kingdom

McDermott Will & Emery on 9/3/2019

McDermott’s annual European Healthcare Private Equity Leadership Forum is a must-attend event for executives from top management teams, health and life sciences companies and providers, private equity, family offices,...more

Top Trends in H1 2016 Digital Health Investments

Fenwick & West Life Sciences Group on 9/2/2016

A few months ago, following our fifth annual Digital Health Summit, the attendees made some predictions about product development and investment in the rapidly growing sector. Now that we are more than halfway through the...more

Key Digital Health Investment Trends to Watch

Fenwick & West Life Sciences Group on 9/1/2015

Our fourth annual Digital Health Summit brought together a select group of investors active in the digital health, life sciences, medical device, and healthcare industries for a one-day meeting to discuss the future of...more

Digital Health Investments Top $2.6B* in the First Six Months of 2014

Fenwick & West Life Sciences Group on 8/1/2014

Thanks to an impressive showing in April, digital health investment in the first half of 2014 totaled $2.676 billion. There were a total of 38 deals for $20 million or more from January through June, with more than two-thirds...more

17 Results

View per page

Page: of 1

Today's Popular Updates › Healthcare › Investors

"My best business intelligence, in one easy email…"